|
1
|
Proliferating dendritic cell progenitors in human blood.
|
J Exp Med
|
1994
|
7.67
|
|
2
|
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.
|
J Exp Med
|
1996
|
5.29
|
|
3
|
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
|
J Immunol Methods
|
1996
|
4.87
|
|
4
|
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.
|
J Exp Med
|
1999
|
4.20
|
|
5
|
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.
|
J Immunol Methods
|
1999
|
3.09
|
|
6
|
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential.
|
Immunity
|
2000
|
2.93
|
|
7
|
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
|
Ann Oncol
|
2006
|
2.88
|
|
8
|
Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.
|
J Exp Med
|
1990
|
2.82
|
|
9
|
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells.
|
J Exp Med
|
1990
|
2.21
|
|
10
|
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression.
|
Proc Natl Acad Sci U S A
|
1997
|
1.85
|
|
11
|
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells.
|
J Immunol
|
2000
|
1.32
|
|
12
|
Human decidua contains potent immunostimulatory CD83(+) dendritic cells.
|
Am J Pathol
|
2000
|
1.24
|
|
13
|
Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture.
|
J Exp Med
|
1992
|
1.18
|
|
14
|
Listeria monocytogenes-infected human dendritic cells: uptake and host cell response.
|
Infect Immun
|
2000
|
1.14
|
|
15
|
Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells.
|
Blood
|
2000
|
1.13
|
|
16
|
A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles.
|
J Gen Virol
|
2000
|
1.10
|
|
17
|
Dendritic cells: multi-lineal and multi-functional.
|
Immunol Today
|
2000
|
1.10
|
|
18
|
Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines.
|
J Leukoc Biol
|
2000
|
1.08
|
|
19
|
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.
|
Gene Ther
|
2009
|
1.05
|
|
20
|
Migration of dendritic cells in 3D-collagen lattices. Visualisation of dynamic interactions with the substratum and the distribution of surface structures via a novel confocal reflection imaging technique.
|
Adv Exp Med Biol
|
1997
|
1.05
|
|
21
|
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
|
Br J Cancer
|
2002
|
1.03
|
|
22
|
Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis.
|
Blood
|
2000
|
1.01
|
|
23
|
[Malignant melanoma of the lacrimal sac].
|
Ophthalmologe
|
2008
|
0.95
|
|
24
|
MHC class II and CD40 play opposing roles in dendritic cell survival.
|
Eur J Immunol
|
2000
|
0.95
|
|
25
|
Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells.
|
J Immunol
|
1995
|
0.94
|
|
26
|
Antibodies against listerial protein 60 act as an opsonin for phagocytosis of Listeria monocytogenes by human dendritic cells.
|
Infect Immun
|
2001
|
0.94
|
|
27
|
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.
|
Int J Cancer
|
2001
|
0.93
|
|
28
|
CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
|
J Immunol
|
2000
|
0.92
|
|
29
|
Murine epidermal Langerhans cells as a model to study tissue dendritic cells.
|
Adv Exp Med Biol
|
1993
|
0.92
|
|
30
|
Interaction of Neisseria meningitidis with human dendritic cells.
|
Infect Immun
|
2001
|
0.91
|
|
31
|
Classical chemotherapy for metastatic melanoma.
|
Clin Exp Dermatol
|
2000
|
0.89
|
|
32
|
Functions of myeloid and lymphoid dendritic cells.
|
Immunol Lett
|
2000
|
0.87
|
|
33
|
Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique.
|
J Invest Dermatol
|
1992
|
0.86
|
|
34
|
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.
|
Cell Death Differ
|
2000
|
0.86
|
|
35
|
Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.
|
Melanoma Res
|
2000
|
0.83
|
|
36
|
Dendritic cell production of cytokines and responses to cytokines.
|
Int Rev Immunol
|
1990
|
0.83
|
|
37
|
Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression.
|
Scand J Immunol
|
2003
|
0.83
|
|
38
|
[Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)].
|
Hautarzt
|
1998
|
0.82
|
|
39
|
Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
|
Br J Dermatol
|
1997
|
0.82
|
|
40
|
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
|
Hum Gene Ther
|
1999
|
0.80
|
|
41
|
Dendritic cell activation by danger and antigen-specific T-cell signalling.
|
Exp Dermatol
|
2000
|
0.80
|
|
42
|
Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study.
|
Melanoma Res
|
1996
|
0.79
|
|
43
|
[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature].
|
Hautarzt
|
1998
|
0.79
|
|
44
|
Recurrent herpes simplex virus-induced erythema multiforme: different HLA-DQB1 alleles associate with severe mucous membrane versus skin attacks.
|
Scand J Immunol
|
1998
|
0.79
|
|
45
|
TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: loss of immunogenic peptides and impairment of antigen-independent T cell clustering.
|
Adv Exp Med Biol
|
1995
|
0.78
|
|
46
|
Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis.
|
J Invest Dermatol
|
1999
|
0.78
|
|
47
|
Isolation, enrichment, and culture of murine epidermal langerhans cells.
|
Methods Mol Med
|
2001
|
0.78
|
|
48
|
Severe bullous drug reactions treated successfully with cyclophosphamide.
|
Br J Dermatol
|
1998
|
0.77
|
|
49
|
Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha.
|
Arch Dermatol Res
|
1996
|
0.75
|
|
50
|
[Nevus of Ota and choroid melanoma].
|
Hautarzt
|
2001
|
0.75
|
|
51
|
Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
|
Melanoma Res
|
1998
|
0.75
|
|
52
|
Fluorescein-guided confocal laser endomicroscopy for the detection of ipilimumab-induced colitis.
|
Endoscopy
|
2012
|
0.75
|
|
53
|
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
|
J Mol Med (Berl)
|
1997
|
0.75
|